Del Gatto F, Breathnach R
Institut National de la Santé et de la Recherche Médicale U211, Institut de Biologie-Centre Hospitalier Régional, Nantes, France.
Mol Cell Biol. 1995 Sep;15(9):4825-34. doi: 10.1128/MCB.15.9.4825.
Two alternative exons, BEK and K-SAM, code for part of the ligand binding site of fibroblast growth factor receptor 2. Splicing of these exons is mutually exclusive, and the choice between them is made in a tissue-specific manner. We identify here pre-mRNA sequences involved in controlling splicing of the K-SAM exon. The short K-SAM exon sequence 5'-TAGGGCAGGC-3' inhibits splicing of the exon. This inhibition can be overcome by mutating either the exon's 5' or 3' splice site to make it correspond more closely to the relevant consensus sequence. Two separate sequence elements in the intron immediately downstream of the K-SAM exon, one of which is a sequence rich in pyrimidines, are both needed for efficient K-SAM exon splicing. This is no longer the case if either the exon's 5' or 3' splice site is reinforced. Furthermore, if the exon inhibitory sequence is removed, the intron sequences are not required for splicing of the K-SAM exon in a cell line which normally splices this exon. At least three elements are thus involved in controlling splicing of the K-SAM exon: suboptimal 5' and 3' splice sites, an exon inhibitory sequence, and intron activating sequences.
两个可变外显子BEK和K-SAM编码成纤维细胞生长因子受体2配体结合位点的一部分。这些外显子的剪接是相互排斥的,并且它们之间的选择是以组织特异性方式进行的。我们在此鉴定了参与控制K-SAM外显子剪接的前体mRNA序列。短的K-SAM外显子序列5'-TAGGGCAGGC-3'抑制该外显子的剪接。通过将外显子的5'或3'剪接位点突变使其更接近相关共有序列,可以克服这种抑制作用。K-SAM外显子下游紧邻的内含子中有两个独立的序列元件,其中一个是富含嘧啶的序列,高效剪接K-SAM外显子两者均需。如果外显子的5'或3'剪接位点得到加强,则情况不再如此。此外,如果去除外显子抑制序列,在通常剪接该外显子的细胞系中,K-SAM外显子的剪接不需要内含子序列。因此,至少有三个元件参与控制K-SAM外显子的剪接:次优的5'和3'剪接位点、一个外显子抑制序列和内含子激活序列。